Research
-
Disparate Aging: The Role of Education and Socioeconomic Gradients in Future Health and Disability in an International Context
If on one side ageing is driven by biological changes, on the other side the ageing itself reflects the accumulated effects of one’s exposure to a history of external risks, and can further be influenced by social changes, such as isolation and loss of loved ones.
Categorized in -
Reporting of Infectious Diseases in the United States During the Coronavirus Disease 2019 (COVID-19) Pandemic
Reporting of infectious diseases other than COVID-19 has been greatly decreased throughout the COVID-19 pandemic.
Categorized in -
Adolescent Peer Influence on Eating Behaviors via Social Media: Scoping Review
The influence of social media among adolescent peer groups can be a powerful change agent.
Categorized in -
Access to the 340B Drug Pricing Program: Is There Evidence of Strategic Hospital Behavior?
Some hospitals adjust their measure that identifies hospitals that treat a disproportionate share of low-income patients to gain 340B eligibility.
Categorized in -
On All Accounts: Cost-Effectiveness Analysis of Limited Preoperative Optimization Efforts Before Colon Cancer Surgery
Reports suggest that preoperative optimization of a patient’s serious comorbidities is associated with a reduction in postoperative complications.
Categorized in -
Parents’ Perceived Neighborhood Safety and Children’s Cognitive Performance: Complexities by Race, Ethnicity, and Cognitive Domain
This study examines racial/ethnic variations in the effect of parents’ subjective neighborhood safety on children’s cognitive performance.Â
Categorized in -
Assessing the Quality of SK&A’s Office-Based Physician Database for Identifying Oncologists
Schaeffer experts assess the quality of one of the most commonly used commercial databases, SK&A’s office-based physician database.
Categorized in -
Cost- Effectiveness of Total State Coverage for Hepatitis C Medications
A Medicaid-Medicare partnership could cover lifesaving hepatitis C medications — and still save $1 to $1.1 billion over 25 years.
Categorized in -
Impacts of First-in-Class Drug Approvals on Future in-Class Innovation
Some claim that FDA approval of drugs with uncertain efficacy today will slow future innovation. In fact, the relationship is much more complex.
Categorized in -
A Megastudy of Text-Based Nudges Encouraging Patients to Get Vaccinated at an Upcoming Doctor’s Appointment
This study evaluated the impact of 19 nudges delivered to patients via text message and designed to boost the adoption of the influenza vaccine.
Categorized in